Genomics-Palooza, Diagnostics Fraud, and Biblical Prophets on the Future of Biotech

What a week for Americans . . . What a week for genomics! The Supreme Court rulings that Americans can keep their Obamacare and can all get married - no matter what state they live in - added the final good news to a week of genomics festivities around the country. But it's not all positive news this week. The New York Times featured a diagnostics company under review by Medicare for fraud. Allegedly, the New Orleans based Renaissance Rx has been paying doctors to sign up patients for a huge trial of genomic based tests, even when the patients didn't qualify.